Jared Kelly: Excited to advance cancer research in my hometown

In reposting UChicago Medicine’s original announcement, Jared Kelly, CEO of Oncolytics Biotech, made the following post on LinkedIn:

Much needed in a city full of talented professionals who have not been able to contribute to drug development in a way we have all wanted. Should be great all around addition to the city and the oncology space. Excited to work with AbbVie and University of Chicago Medicine Comprehensive Cancer Center on developing studies and projects to treat cancer here in my hometown.

In the original company post, UChicago Medicine wrote:

UChicago Medicine is one year away from the opening of the AbbVie Foundation Cancer Pavilion, which will be Illinois’ first standalone facility focused entirely on cancer care. With world-class treatment and clinical trials housed under one roof, the pavilion marks a new era in cancer care for the South Side and beyond.

Article attached to the post.